YTHDC1 and acute myeloid leukemia: According to this study, m6A and YTHDC1 appear to support the cancerous phenotype of AML cells by forming nuclear condensates (nYACs) that protect the mRNAs’ coding for oncogenes from degradation by the PAXT (polyA tail exosome) complex.